Cargando…
Surrogate Markers of Cardiovascular Risk and Chronic Obstructive Pulmonary Disease: A Large Case-Controlled Study
Cardiovascular disease is a common comorbidity and cause of mortality in chronic obstructive pulmonary disease. A better understanding of mechanisms of cardiovascular risk in chronic obstructive pulmonary disease patients is needed to improve clinical outcomes. We hypothesized that such patients hav...
Autores principales: | Fisk, Marie, McEniery, Carmel M., Gale, Nichola, Mäki-Petäjä, Kaisa, Forman, Julia R., Munnery, Margaret, Woodcock-Smith, Jean, Cheriyan, Joseph, Mohan, Divya, Fuld, Jonathan, Tal-Singer, Ruth, Polkey, Michael I., Cockcroft, John R., Wilkinson, Ian B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott, Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805278/ https://www.ncbi.nlm.nih.gov/pubmed/29358458 http://dx.doi.org/10.1161/HYPERTENSIONAHA.117.10151 |
Ejemplares similares
-
The p38 mitogen activated protein kinase inhibitor losmapimod in chronic obstructive pulmonary disease patients with systemic inflammation, stratified by fibrinogen: A randomised double-blind placebo-controlled trial
por: Fisk, Marie, et al.
Publicado: (2018) -
Quantitative (18)F-fluorodeoxyglucose positron emission tomography/computed tomography to assess pulmonary inflammation in COPD
por: Vass, Laurence, et al.
Publicado: (2021) -
Vascular inflammation and aortic stiffness: potential mechanisms of increased vascular risk in chronic obstructive pulmonary disease
por: Fisk, Marie, et al.
Publicado: (2018) -
Cardiovascular risk prediction using physical performance measures in COPD: results from a multicentre observational study
por: Fermont, Jilles M, et al.
Publicado: (2020) -
Risk assessment for hospital admission in patients with COPD; a multi-centre UK prospective observational study
por: Fermont, Jilles M., et al.
Publicado: (2020)